Showing 531-540 of 1645 results for "".
Recognize and Prevent Polypharmacy in MS Patients
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/recognize-and-prevent-polypharmacy-in-ms-patients/30836/Minimizing drug-to-drug interactions is paramount in finding an appropriate treatment regimen, ensuring safety, and encouraging good quality of life.Shocking Seizures: What to Know About VNS
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/shocking-seizures-what-to-know-about-vns/30794/A specialist weighs in on when to consider vagus nerve stimulation and the latest research in neurostimulation for epilepsy patientsThe Evolving Role of Neurologists in PFO Closure
https://practicalneurology.com/diseases-diagnoses/stroke/the-evolving-role-of-neurologists-in-pfo-closure/30296/How neurology plays a central role in determining cause and treatment of stroke.Discontinuing Disease-Modifying Therapy in Multiple Sclerosis: Should You Have an Exit Strategy?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/discontinuing-disease-modifying-therapy-in-multiple-sclerosis-should-you-have-an-exit-strategy/30303/Two experts sound off on the implications of indefinite treatment and whether DMTs should be stopped.Global Outcomes Data and Possible New Therapies in the Huntington's Pipeline
https://practicalneurology.com/diseases-diagnoses/movement-disorders/global-outcomes-data-and-possible-new-therapies-in-the-huntingtons-pipeline/30606/Researchers are focused on patient outcomes on a global scale and join clinicians in the vigil for new drug approvals.In-Focus: Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/in-focus-parkinsons-disease/30471/The Most Unsettling Trends Facing Physicians: What to Expect and What to Do Today
https://practicalneurology.com/columns/practice-management/the-most-unsettling-trends-facing-physicians-what-to-expect-and-what-to-do-today/30764/The right approaches to financial planning can help protect and grow a physician's assets, even as troubling trends persist.Study Shows Promise for LRRK2 Inhibitor Approach to Parkinson's
https://practicalneurology.com/diseases-diagnoses/movement-disorders/study-shows-promise-for-lrrk2-inhibitor-approach-to-parkinsons/30644/Research is focusing on the LRRK2 gene as a means of neuroprotection.The Many Challenges of Drug-Resistant Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/the-many-challenges-of-drug-resistant-epilepsy/31834/Recognizing and appropriately treating drug-resistant epilepsy is paramount.Letters
https://practicalneurology.com/columns/practice-management/letters/30698/